News
QRxPharma Announces Interim Analysis of Final Pivotal Phase 3 Study for MoxDuo®IR
September 1, 2010 11:36 am | by Bio-Medicine.Org | CommentsSYDNEY, Australia and BEDMINSTER, N.J., Sept. 1 /- QRxPharma (ASX: QRX and OTCQX: QRXPY) announced today a successful interim analysis of its final MoxDuo IR pivotal Phase 3 study required for New Drug Application (NDA) submission. The analysis indicated the planned sample size of 140...
NCPA Launches www.PharmacyMatching.com to Connect Independent Pharmacy Buyers and Sellers
September 1, 2010 11:36 am | by Bio-Medicine.Org | CommentsALEXANDRIA, Va., Sept. 1 /PRNewswire-USNewswire/ -- The National Community Pharmacists Association today announced the launch of a new website, www.PharmacyMatching.com to bring together independent pharmacy owners preparing to sell their pharmacy, existing owners who desire additional...
Radiation Oncology Services of America, Inc. to Work With Washington University on Quality Assurance Initiative
September 1, 2010 11:36 am | by Bio-Medicine.Org | CommentsNASHVILLE, Tenn., Sept. 1 /- Radiation Oncology Services of America, Inc. (ROSA), a subsidiary of Ambulatory Services of America, Inc. (ASA), announced today that it has entered into an agreement with the Department of Radiation Oncology at the Washington University in St. Louis School of...
MedWOW Adds Comparison Tool for Shoppers' Medical Equipment - Offers eBook Free to New Registrants
September 1, 2010 11:36 am | by Bio-Medicine.Org | CommentsNICOSIA, Cyprus, Sept. 1 /- MedWOW.com, the global online marketplace for medical equipment , is pleased to announce the addition of its newest consumer-focused tool: a comparison feature that allows buyers to select as many items as they would like to compare, assisting them in making...
Volunteers needed for calorie consumption and exercise study
September 1, 2010 11:35 am | by Baylor College of Medicine | CommentsThe USDA/ARS Children's Nutrition Research Center at Baylor College of Medicine is recruiting volunteers to participate in a two-visit study for healthy 3- to 5 -year-olds. The purpose of the study is to develop a method to determine calories used in young children by having them wear...
Unilife Corporation Secures FDA 510k Clearance for the Unitract™ 1mL Tuberculin Syringe
September 1, 2010 11:35 am | by Bio-Medicine.Org | CommentsLEWISBERRY, Pa., Sept. 1 /- Unilife Corporation ("Unilife" or "Company") (Nasdaq: UNIS, ASX: UNS), today announced that its Unitract™ Tuberculin (TB) Syringe has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA). The Unitract™ TB...
Metformin May Protect Against Lung Cancer
September 1, 2010 11:33 am | by AACR | CommentsPHILADELPHIA — Metformin, a drug commonly used to treat type 2 diabetes, shows potential in the prevention of tobacco-induced lung tumors, according to early research conducted at the National Cancer Institute (NCI).
Federal Register: Public Workshop on Medical Devices and Nanotechnology: Manufacturing, Characterization, and Biocompatibility Considerations; Correction.
September 1, 2010 11:31 am | by U.S. Food & Drug Administration | CommentsThe FDA is correcting a notice that appeared in the Federal Register of August 23, 2010 (75 FR 51829). The notice announced the public workshop entitled 'Medical Devices & Nanotechnology: Manufacturing, Characterization, and Biocompatibility...
Federal Register: Medical Device User Fee Act; Public Meeting; Request for Comments; Amendment of Notice
September 1, 2010 11:31 am | by U.S. Food & Drug Administration | CommentsThe FDA is announcing an amendment to the notice of a public meeting on the reauthorization of the medical device user fee program. This meeting was announced in the Federal Register of August 13, 2010 (75 FR 49502). The amendment is being made to...
Tygacil (tigecycline): Label Change - Increased Mortality Risk
September 1, 2010 11:30 am | by U.S. Food & Drug Administration | CommentsHealthcare professionals should consider alternatives to Tygacil in patients with severe infections.
Omnicare buys Continuing Care Rx
September 1, 2010 9:45 am | by The Associated Press | CommentsOmnicare Inc., which dispenses drugs to nursing homes and long-term care facilities, said Wednesday it bought privately held Continuing Care Rx for an undisclosed amount.Continuing Care, based in Harrisburg, Pa., provides pharmacy services to residents of long-term care and other facilities in...
LHC Group acquires home health agency
September 1, 2010 8:45 am | by The Associated Press | CommentsHome health provider LHC Group Inc. says it has acquired the assets of a home health agency in Harrodsburg, Ky.Terms of the deal with James B. Haggin Memorial Hospital were not revealed. Lafayette-based LHC Group will take over the operations of Haggin Home Health. The agency will be renamed...
Results From Investigator-Sponsored Trials Presented at SSIEM Conference
September 1, 2010 7:31 am | by Bio-Medicine.Org | CommentsNOVATO, Calif., Sept. 1 /- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) announced today that results from investigator-sponsored studies on Kuvan (sapropterin dihydrochloride) are being presented at the 2010 Annual Symposium of the Society for The Study of Inborn Errors of Metabolism...
FoldRx to be acquired by Pfizer
September 1, 2010 6:37 am | by Mass High Tech: The Journal of New England Technology | CommentsCambridge small molecule therapeutics firm FoldRx Pharmaceuticals Inc. is going to be acquired by pharmaceutical giant Pfizer Inc. as part of the latter company’s overall strategy to increase its pipeline of drugs to treat rare diseases.
<i>Tech across New England: </i>ProThera Biologics takes holistic approach to treating inflammation
September 1, 2010 6:34 am | by Mass High Tech: The Journal of New England Technology | CommentsMass High Tech looked at startups poised to lead the economic recovery because of their technology, management team or growth potential. ProThera Biologics develops technology centered on a protein in the blood that regulates the immune system and is the key to controlling sepsis...
